Pharmical
ActiveSummary
Pharmical has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €309,612 and a net result of €98,170. Equity is growing by about 35% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
18-08
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 18 days late
2025
31-12
Financial
Highest result from 2023 to 2025net €98,170 ▲91.5%
Operating result €30,996, net result €98,170, both a record.
26-06
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial
Back to profitnet €51,267
Net result €51,267 after one loss-making year.
31-12
Financial
Equity above €200,000equity €211,443 ▲32%
Equity rises from €160,176 to €211,443.
30-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.